Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis

REFERENCES

1. 1.↵
   2. Polman CH,
   3. Reingold SC,
   4. Banwell B, et al

   . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

   CrossRefPubMedWeb of Science
2. 2.↵
   2. McDonald WI,
   3. Compston A,
   4. Edan G, et al

   . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121–27 doi:10.1002/ana.1032 pmid:11456302

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Montalban X,
   3. Tintoré M,
   4. Swanton J, et al

   . MRI criteria for MS in patients with clinically isolated syndromes. Neurology 2010;74:427–34 doi:10.1212/WNL.0b013e3181cec45c pmid:20054006

   Abstract/FREE Full Text
4. 4.↵
   2. Solomon AJ,
   3. Klein EP,
   4. Bourdette D

   . “Undiagnosing” multiple sclerosis: the challenge of misdiagnosis in MS. Neurology 2012;78:1986–91 doi:10.1212/WNL.0b013e318259e1b2 pmid:22581930

   Abstract/FREE Full Text
5. 5.↵
   2. Solomon AJ,
   3. Bourdette DN,
   4. Cross AH, et al

   . The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study. Neurology 2016;87:1393–99 doi:10.1212/WNL.0000000000003152 pmid:27581217

   Abstract/FREE Full Text
6. 6.↵
   2. Lebrun C,
   3. Cohen M,
   4. Chaussenot A, et al

   . A prospective study of patients with brain MRI showing incidental T2 hyperintensities addressed as multiple sclerosis: a lot of work to do before treating. Neurol Ther 2014;3:123–32 doi:10.1007/s40120-014-0024-7 pmid:26000228

   CrossRefPubMed
7. 7.↵
   2. Liu S,
   3. Kullnat J,
   4. Bourdette D, et al

   . Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients. Mult Scler 2013;19:1101–05 doi:10.1177/1352458512471874 pmid:23380650

   CrossRefPubMed
8. 8.↵
   2. Traboulsee A,
   3. Simon JH,
   4. Stone L, et al

   . Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis. AJNR Am J Neuroradiol 2016;37:394–401 doi:10.3174/ajnr.A4539 pmid:26564433

   Abstract/FREE Full Text
9. 9.↵
   2. Solomon AJ,
   3. Schindler MK,
   4. Howard DB, et al

   . “Central vessel sign” on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine. Ann Clin Transl Neurol 2016;3:82–87 doi:10.1002/acn3.273 pmid:26900578

   CrossRefPubMed
10. 10.↵
    2. Absinta M,
    3. Sati P,
    4. Schindler M, et al

    . Persistent 7-Tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. J Clin Invest 2016;126:2597–609 doi:10.1172/JCI86198 pmid:27270171

    CrossRefPubMed
11. 11.↵
    2. Kilsdonk ID,
    3. Wattjes MP,
    4. Lopez-Soriano A, et al

    . Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla. Eur Radiol 2014;24:841–49 doi:10.1007/s00330-013-3080-y pmid:24317461

    CrossRefPubMed
12. 12.↵
    2. Filippi M,
    3. Rocca MA,
    4. Ciccarelli O, et al

    ; MAGNIMS Study Group. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016;15:292–303 doi:10.1016/S1474-4422(15)00393-2 pmid:26822746

    CrossRefPubMed
13. 13.↵
    2. Dale AM,
    3. Fischl B,
    4. Sereno MI

    . Cortical surface-based analysis, I: segmentation and surface reconstruction. Neuroimage 1999;9:179–94 doi:10.1006/nimg.1998.0395 pmid:9931268

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Fischl B,
    3. Sereno MI,
    4. Dale AM

    . Cortical surface-based analysis, II: inflation, flattening, and a surface-based coordinate system. Neuroimage 1999;9:195–207 doi:10.1006/nimg.1998.0396 pmid:9931269

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Woolrich MW,
    3. Jbabdi S,
    4. Patenaude B, et al

    . Bayesian analysis of neuroimaging data in FSL. Neuroimage 2009;45(1 Suppl):S173–86 doi:10.1016/j.neuroimage.2008.10.055 pmid:19059349

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Jenkinson M,
    3. Bannister P,
    4. Brady M, et al

    . Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825–41 doi:10.1006/nimg.2002.1132 pmid:12377157

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Rorden C,
    3. Brett M

    . Stereotaxic display of brain lesions. Behav Neurol 2000;12:191–200 doi:10.1155/2000/421719 pmid:11568431

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Okuda DT,
    3. Siva A,
    4. Kantarci O, et al

    ; Radiologically Isolated Syndrome Consortium (RISC), Club Francophone de la Sclérose en Plaques (CFSEP). Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One 2014;9:e90509 doi:10.1371/journal.pone.0090509 pmid:24598783

    CrossRefPubMed
19. 19.↵
    2. Gelman A,
    3. Jakulin A,
    4. Pittau MG, et al

    . A weakly informative default prior distribution for logistic and other regression models. Ann Appl Stat 2008;2:1360–83 doi:10.1214/08-AOAS191

    CrossRefWeb of Science
20. 20.↵
    2. Rudick RA,
    3. Miller AE

    . Multiple sclerosis or multiple possibilities: the continuing problem of misdiagnosis. Neurology 2012;78:1904–06 doi:10.1212/WNL.0b013e318259e2e2 pmid:22581931

    FREE Full Text
21. 21.↵
    2. Hearshen DO,
    3. Ellis JH,
    4. Carson PL, et al

    . Boundary effects from opposed magnetization artifact in IR images. Radiology 1986;160:543–47 doi:10.1148/radiology.160.2.3014600 pmid:3014600

    CrossRefPubMed
22. 22.↵
    2. Pusey E,
    3. Lufkin RB,
    4. Brown RK, et al

    . Magnetic resonance imaging artifacts: mechanism and clinical significance. Radiographics 1986;6:891–911 doi:10.1148/radiographics.6.5.3685515 pmid:3685515

    CrossRefPubMed
23. 23.↵
    2. Dal-Bianco A,
    3. Grabner G,
    4. Kronnerwetter C, et al

    . Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol 2017;133:25–42 doi:10.1007/s00401-016-1636-z pmid:27796537

    CrossRefPubMed
24. 24.↵
    2. Haacke EM,
    3. Makki M,
    4. Ge Y, et al

    . Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009;29:537–44 doi:10.1002/jmri.21676 pmid:19243035

    CrossRefPubMed
25. 25.↵
    2. Frischer JM,
    3. Weigand SD,
    4. Guo Y, et al

    . Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol 2015;78:710–21 doi:10.1002/ana.24497 pmid:26239536

    CrossRefPubMed
26. 26.↵
    2. Chawla S,
    3. Kister I,
    4. Wuerfel J, et al

    . Iron and non-iron-related characteristics of multiple sclerosis and neuromyelitis optica lesions at 7T MRI. AJNR Am J Neuroradiol 2016;37:1223–30 doi:10.3174/ajnr.A4729 pmid:27012298

    Abstract/FREE Full Text
27. 27.↵
    2. Kilsdonk ID,
    3. Lopez-Soriano A,
    4. Kuijer JP, et al

    . Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics. J Neurol 2014;261:1356–64 doi:10.1007/s00415-014-7351-6 pmid:24777693

    CrossRefPubMed
28. 28.↵
    2. Mistry N,
    3. Abdel-Fahim R,
    4. Samaraweera A, et al

    . Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. Mult Scler 2016;22:1289–96 doi:10.1177/1352458515616700 pmid:26658816

    CrossRefPubMed
29. 29.↵
    2. Mistry N,
    3. Dixon J,
    4. Tallantyre E, et al

    . Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain. JAMA Neurol 2013;70:623–28 doi:10.1001/jamaneurol.2013.1405 pmid:23529352

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Lummel N,
    3. Boeckh-Behrens T,
    4. Schoepf V, et al

    . Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis? Neuroradiology 2011;53:311–17 doi:10.1007/s00234-010-0736-z pmid:20585764

    CrossRefPubMed
31. 31.↵
    2. van Walderveen MA,
    3. Kamphorst W,
    4. Scheltens P, et al

    . Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282–88 doi:10.1212/WNL.50.5.1282 pmid:9595975

    Abstract/FREE Full Text
32. 32.↵
    2. Bitsch A,
    3. Kuhlmann T,
    4. Stadelmann C, et al

    . A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 2001;49:793–96 doi:10.1002/ana.1053 pmid:11409432

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Barkhof F,
    3. Bruck W,
    4. De Groot CJ, et al

    . Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 2003;60:1073–81 doi:10.1001/archneur.60.8.1073 pmid:12925362

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Brück W,
    3. Bitsch A,
    4. Kolenda H, et al

    . Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783–93 doi:10.1002/ana.410420515 pmid:9392578

    CrossRefPubMedWeb of Science